Leptin receptor (LepR) modulation represents an emerging therapeutic strategy for neurodegenerative diseases. Leptin, primarily known as an adipocyte-derived hormone regulating energy homeostasis, also exerts profound effects on brain function through its receptor (LepR/LEPR), a cytokine-type I receptor widely expressed in the central nervous system[1][2].
The leptin-APJ system influences multiple processes critical to neurodegeneration, including neurogenesis, synaptic plasticity, neuroinflammation, mitochondrial function, and neuronal survival. Leptin signaling through JAK/STAT, PI3K/AKT, and MAPK pathways promotes neuronal health and has been implicated in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis.
Leptin is a 167-amino acid hormone produced primarily by adipocytes:
The leptin receptor exists in multiple isoforms:
| Isoform | Structure | Expression | Function |
|---|---|---|---|
| LepRa | Short cytoplasmic | Choroid plexus, BBB | Leptin transport |
| LepRb (Long) | Full cytoplasmic | Hypothalamus, hippocampus | Full signaling |
| LepRc | Soluble | Blood | Decoy receptor |
LepRb is the main signaling isoform containing:
Primary signaling pathway for LepR:
Leptin → LepRb → JAK2 → STAT3 → Nuclear transcription
→ STAT5 → Gene expression
Key effects:
Leptin activates PI3K-AKT signaling:
Leptin activates ERK1/2:
Leptin promotes neurogenesis in key brain regions[3]:
Mechanisms:
Leptin modulates synaptic function[4]:
The hippocampal effects are particularly relevant for:
Leptin modulates neuroinflammation[5]:
In obesity-associated neurodegeneration:
Leptin is central to metabolic dysfunction in neurodegeneration[6]:
Metabolic dysfunction is a key feature of:
Leptin promotes mitochondrial health:
Leptin has multiple beneficial effects in AD[2:1]:
| Effect | Mechanism | Evidence |
|---|---|---|
| Amyloid Reduction | Autophagy enhancement | Mouse models |
| Tau Modification | GSK-3β inhibition | Cell culture |
| Synaptic Protection | Synaptic plasticity | In vivo |
| Cognitive Improvement | Multiple | Clinical correlation |
Clinical Evidence:
Leptin signaling is altered in PD[7]:
Therapeutic Potential:
Leptin is implicated in ALS[8]:
Leptin shows protective effects:
| Compound | Type | Status | Notes |
|---|---|---|---|
| Recombinant Leptin | Protein | Approved (obesity) | CNS penetration limited |
| Leptin Analogues | Protein | Research | Improved stability |
| Small Molecule Agonists | Small molecule | Preclinical | Oral availability |
| Peptide Mimetics | Peptide | Research | BBB penetration |
Since leptin resistance is common:
Limited but growing evidence:
Potential combinations:
| Combination | Rationale |
|---|---|
| Leptin + Exercise | Synergistic neurogenesis |
| Leptin + GLP-1 | Metabolic benefits |
| Leptin + Anti-amyloid | Multi-target approach |
| Leptin + Physical therapy | Functional improvement |
Leptin in brain function. Nat Rev Neurosci. 2007. ↩︎
Leptin and Alzheimer's disease. J Alzheimers Dis. 2012. ↩︎ ↩︎
Leptin and hippocampal neurogenesis. Hippocampus. 2018. ↩︎
Leptin and synaptic plasticity. Brain Res. 2010. ↩︎
Leptin and neuroinflammation. J Neuroinflammation. 2018. ↩︎
Leptin in metabolic dysfunction. Nat Rev Neurosci. 2011. ↩︎
Leptin receptor signaling in Parkinson's disease. Exp Neurol. 2015. ↩︎
Leptin in ALS pathogenesis. Neurology. 2016. ↩︎